The effects on mood of adjunctive single-family and multi-family group therapy in the treatment of hospitalized patients with major depression. A 15-month follow-up study by Lemmens, Gilbert M D et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Regular Article 
 Psychother Psychosom 2009;78:98–105 
 DOI: 10.1159/000201935 
 The Effects on Mood of Adjunctive Single-Family 
and Multi-Family Group Therapy in the Treatment 
of Hospitalized Patients with Major Depression 
 A 15-Month Follow-Up Study  
 Gilbert M.D Lemmens a    Ivan Eisler c    Ann Buysse b    Els Heene b    
Koen Demyttenaere a  
 a  University Psychiatric Centre K.U.Leuven, Campus Leuven,  Leuven , and  b  Faculty of Psychology and Educational 
Sciences, University of Ghent,  Ghent , Belgium;  c  Section of Family Therapy, Institute of Psychiatry, Kings College, 
University of London,  London , UK
 
patient early on compared to those in the treatment as usu-
al condition.  Conclusions: This study suggests that single-
family and multi-family therapy may benefit hospitalized 
patients with major depression, and may help the partners 
of the patients to become aware of the patient’s improve-
ment more quickly.  Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Major depression is a highly prevalent, often recurring 
and persistent disorder  [1–6] . One of the factors that has 
consistently been linked with its course and treatment re-
sponse is the patient’s family environment  [7] . Hostility 
and criticism from the partner, marital distress and family 
functioning have been reported to predict long-term out-
come and relapse rates  [8–10] leading to the development 
of a number family-based psychosocial interventions.
 The literature on empirically supported psychosocial 
interventions for depression includes different  forms of 
couple therapy such as behavioural marital therapy  [11–
14] , conjoint interpersonal therapy  [15] , emotion-focused 
therapy  [16] , enhancing marital intimacy therapy  [17, 18] 
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 Abstract 
 Background: Family-based interventions have been shown 
to be effective in the treatment of depression, but they have 
seldom been studied in hospitalized depressed patients. 
This study assesses the value of the additional use of single-
family or multi-family group therapy within this patient pop-
ulation.  Methods: Eighty-three patients were randomly as-
signed to: (1) the treatment programme as usual (n = 23),
(2) treatment as usual combined with single-family therapy 
(n = 25) or (3) treatment as usual combined with multi-fam-
ily group therapy (n = 35). Follow-up assessments were made 
at 3 months and 15 months.  Results: Multi-family group and 
single-family therapy conditions showed significantly high-
er rates of treatment responders than the group receiving 
the usual treatment (49, 24 and 9%, respectively), and higher 
rates of patients no longer using antidepressant medication 
(26, 16 and 0%, respectively) at 15 months. Partners taking 
part in the family treatments were significantly more likely 
to notice the improvements in the emotional health of the 
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and systemic couple therapy  [19] . Although these have 
been mainly fairly small studies, they indicate that couple 
therapy has similar efficacy to cognitive therapy or anti-
depressant medication, particularly for distressed cou-
ples  [20, 21] . This has recently been reflected in the UK 
national clinical guidelines from the National Institute 
for Health and Clinical Excellence (NICE 2007) which 
recommend couple-focused interventions as one of the 
evidence-based treatments for depression.
 The above studies have been conducted on a relatively 
select group of depressed patients. Most participants were 
female outpatients with moderately severe depressive 
complaints, were taking no antidepressant medication, 
did not have a diagnosis of psychiatric comorbidity and 
often had marital problems. Most of the published stud-
ies did not include a control condition, nor did they in-
vestigate the efficacy of combining psychosocial and 
pharmacological treatment.
 Only 2 randomized controlled studies have involved 
patients whose depression was severe enough to require 
hospitalization. The results have been mixed, with 1 study 
 [22] showing a possible negative effect at the 18-month 
follow-up of an inpatient psycho-educational family in-
tervention and 1 study  [23] showing higher rates of im-
provement and greater proportions of patients whose de-
pression remitted after family therapy in the post-hospital 
period. There are virtually no empirical data on the use of 
other family intervention formats such as multi-family 
therapy groups, which are frequently offered to inpatients 
with major depression and their families  [24–27] .
 The aims of the present study were (1) to investigate the 
efficacy of adding a family intervention to inpatient treat-
ment of depressed individuals and (2) to compare the rela-
tive value of single-family and multi-family group therapy. 
Our primary hypothesis was that patients receiving fam-
ily therapy would have better outcomes than those receiv-
ing only inpatient treatment and standard psychiatric fol-
low-up. The secondary hypothesis was that the patients 
receiving multi-family therapy would have a better out-
come than patients receiving the single-family interven-
tion.
 Method 
 Sample Selection 
 Participants were consecutive referrals to the Anxiety and De-
pression Unit of the University Hospital Leuven who met the in-
clusion criteria for the study: (1) a DSM-IV diagnosis of major 
depressive disorder  [28] , (2) aged 18–65 years, (3) cohabitating 
with a partner for at least 1 year and (4) informed consent pro-
vided by the patient and their partner. Patients were excluded 
from the study if they met DSM-IV criteria for bipolar disorder 
 [28] . Participants received a detailed explanation of the study and 
provided written informed consent.
 Participants 
 Eighty-three patients and their partners participated in this 
study. Their sociodemographic data are shown in  table 1 . No dif-
ferences were found between the treatment groups except that 
those in multi-family therapy were more likely to have been given 
a diagnosis of personality disorders (  2 = 13.7, d.f. = 4, p  ! 0.01). 
The patients were randomized in blocks of 4–7, using a random-
number table and sealed envelopes, to 1 of 3 conditions: (a) the 
treatment programme of the unit, i.e. treatment as usual (TAU), 
(b) TAU combined with single-family therapy (SFT) or (c) TAU 
combined with multi-family group therapy (MFT).
 Description of the Treatment Conditions 
 The treatment programme of the Anxiety and Depression 
Unit,  which lasts about 2–3 months, is available on an inpatient or 
day clinic basis. It has 2 phases: a ‘problem-analysis’ phase (first 
month) and the ‘working through’ phase. During each phase, spe-
cific therapeutic interventions are offered to the patients, mostly 
in a group format and some individually. The therapeutic tech-
niques and interventions within the programme draw on differ-
ent conceptual therapeutic frameworks such as non-verbal ther-
apy (e.g. art therapy and relaxation), cognitive behavioural ther-
apy (e.g. psycho-education, social skills training, functional 
analysis), systemic therapy (e.g. genogram group, communication 
training), pharmacological treatment (all except 1 patient were 
taking antidepressants) and activation (e.g. sport activities and 
ergotherapy). The relatives of newly admitted patients are invited 
for a family meeting to inform them about the unit and to gain 
information about the patient’s pre-admission functioning. After 
discharge, patients are referred to a psychiatrist close to where 
they are living for further care.
 In the SFT condition, patients received TAU plus 7 single-fam-
ily therapy sessions. Conceptually, the model of family therapy 
used was based on systemic couple therapy for depression  [29] , 
incorporating social constructionist and narrative concepts, and 
the family systems-illness model  [30] . In the systemic model, de-
pressive symptoms of the patient are conceptualized in interac-
tional terms, which means that close relationships are seen as 
both influencing and being influenced by the patient and the de-
pressive symptoms. Initially the treatment focuses on exploring 
the depression within its relational context, before looking at oth-
er and wider patterns of interactions and ‘quality of life’ ques-
tions, and ending treatment with the discussion of possible treat-
ment gains and relapse prevention. The aim is not primarily on 
altering relational distress, but to help the couples to cope better 
with the way depression impacts their lives. Some modifications 
were made for the treatment protocol compared to the original 
systemic couple therapy manual described by Jones and Asen  [29] . 
First, the number of sessions was reduced to 6 biweekly sessions 
with the patient and their partner, and a follow-up session after 3 
months. Second, the patient’s children were invited to 2 of the ses-
sions (sessions 2 and 5) with their parents in order to directly pay 
attention to their needs. The ‘children sessions’ were focused 
mainly on issues related to them and they were regarded as the 
main protagonists in these meetings.
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 The sessions followed a predetermined treatment protocol, 
with each session having a specific primary focus: the impact of 
the depression on the family (especially on the couple in session 
1 and on the children in session 2); couple issues (session 3); re-
storing family functioning (in the couple in session 4 and the chil-
dren and the family as a whole in session 5); relapse prevention 
(session 6); stabilizing treatment gains (session 7). Each session 
lasted for 60 min. Major goals of the sessions were: to help the pa-
tients and the families to find better ways of coping with the dif-
ferent stages of the depression and the recovery, to accommodate 
their mutual efforts, to reduce the impact of the depression on the 
family unit, and to promote a better working alliance between the 
patient, the family and the therapeutic team.
 In MFT, patients received TAU plus 7 sessions of multi-family 
group therapy. Conceptually the treatment is similar to the sin-
gle-family therapy format described above, and had a comparable 
structure of the content and the organization of the sessions: 6 
biweekly group sessions and a follow-up session after 3 months. 
Each group consisted of 4–7 patients and their partners (with the 
patients’ children being invited to take part in group sessions 2 
and 5). The multi-family group format affords many opportuni-
ties of helping families to learn from each others’ strengths, to 
reduce the sense of isolation and stigma and to use the group as a 
resource for problem solving [ 24, 31–34 ; for a detailed description 
of the treatment, see Lemmens et al.,  35 ].
 The sessions were conducted by a male/female co-therapy 
team. Sessions lasted about 90 min with a tea break after 60 min. 
The group leaders mainly acted as facilitators of the conversation 
process, encouraging the patients and their family members to 
share their perspectives on depression and family interactions 
and ensuring that all participants were able to express their expe-
riences and perspectives.
 The first sessions of both SFT and MFT took place on average 
5.9  8 2.7 weeks after the start of the admission (i.e. approximate-
ly halfway through the admission). No differences in time to first 
session (F = 0.210, d.f. = 1, p = 0.65) were found between the 2 
family treatments.
 Assessment 
 All patients were, as part of their admission, routinely assessed 
by the junior trainee psychiatrist from the unit, using the Mini 
International Neuropsychiatric Interview, Dutch version 5.0.0. 
(sections A to O)  [36] , and the Hamilton Rating Scale for Depres-
sion. As part of the current study, the patients further completed 
the Beck Depression Inventory (BDI)  [37] , and both they and their 
partners filled in the Dyadic Adjustment Scale (DAS)  [38] and a 
rating of the subjective emotional health (SEH) of their partner 
(‘ How would you describe the current emotional and psychologi-
cal condition of your partner ’) rated on a 4-point Likert scale
(1 = poor, 2 = not very good, 3 = quite good, 4 = very good). The 
BDI and the SEH were re-administered in month 3 (after session 
6) and month 15.
Table 1. Baseline characteristics of the depressed patients in the 3 treatment conditions
MFT  (n = 35) TAU (n = 23) SFT (n = 25) p value
Mean age, years 43.988.3 43.288.4 40.289.1 ns
Gender of patient, % female 80.0 69.6 64.0 ns
Duration of relationship, years 18.7810.0 18.1810.9 14.889.6 ns
Marital status, % married 82.9 91.3 88.0 ns
Number of children, %
0
1–2
>2
28.6
42.8
28.6
30.4
52.2
17.4
24.0
56.0
20.0
ns
Baseline dyadic adjustment scale 98.5823.9 98.1823.5 104.9820.5 ns
Total number of depressive episodes 2.781.4 2.782.1 2.381.4 ns
Recurrent depression, % 74.3 65.2 80.0 ns
Baseline Hamilton Depression Rating Scale 17.986.3 17.985.8 18.085.7 ns
Baseline Beck Depression Inventory 26.689.9 27.3810.5 26.2813.5 ns
Comorbid axis 1, %
No
Anxiety disorder
Substance abuse
Anxiety disorder and substance abuse
5.7
80.0
5.7
8.6
17.4
65.2
0.0
17.4
12.0
80.0
0.0
8.0
ns
Personality disorder, %
No
Yes
Diagnosis deferred on Axis II
20.0
57.1
22.9
34.8
30.4
34.8
36.0
12.0
52.0
0.008a
Duration of hospitalization, weeks 11.384.5 12.683.2 12.483.3 ns
a 2 = 13.7, d.f. = 4, p < 0.01.
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 Treatment Response 
 Response to treatment was measured by changes in the BDI 
scores. In addition to the continuous measures of symptom 
change, we also defined 2 treatment response categories as fol-
lows: (1) ‘remission’ – defined as a BDI score  ! 9, and (2) ‘treatment 
response’ – defined as  6 50% improvement on the BDI. Re-hos-
pitalization rates were assessed at 15 months using a self-report 
and an additional telephone interview if necessary.
 Statistical Analyses 
 Statistical analyses were performed after the completion of all 
treatments and follow-up assessment. Each outcome variable pro-
vided data at 3 time points: baseline, 3 months and 15 months 
follow-up. Statistical analysis of the outcome was conducted on 
an intention-to-treat basis, and any data available from dropouts 
were included. For continuous data, a maximum likelihood ap-
proach (direct likelihood) was used to deal with missing data, 
which produces valid parameter estimates and standard errors as 
long as the dropouts are not informative (missing at random). For 
continuous data, this method is an appropriate alternative to the 
commonly-used techniques, such as analyzing only treatment 
completers or replacing missing values with a baseline value or 
with the last available measurement  [39] , which always yield bi-
ased estimates. For categorical data, a reasonable assumption is 
that dropouts have not made progress, and therefore carrying for-
ward the last available measurement can be justified. Any bias 
introduced in this way is likely to be conservative in this case. In 
order to check for possible bias, the analyses were repeated using 
subjects with complete datasets  [40] .
 The baseline characteristics of the patients in the 3 treatment 
conditions were compared using 1-way ANOVA and   2 analyses. 
Treatment effects were compared using a series of 3 (MFT vs. TAU 
vs. SFT)  ! 3 (baseline vs. 3 months vs. 15 months) linear mixed 
models for repeated measurements (direct likelihood) on the scores 
of the BDI, and using a series of 3 (MFT vs. TAU vs. SFT)  ! 3 (base-
line vs. 3 months vs. 15 months)  ! 2 (patient vs. partner) multi-
variate ANOVA on the scores of the SEH. Differences in treatment 
responders, treatment remission, re-hospitalization, suicide rates, 
and use of antidepressant medication between the treatment con-
ditions were compared using   2 analyses, Fisher’s exact test and 
1-way ANOVA. In order to control for the imbalance resulting 
from the random allocation to the 3 treatment groups, a diagnosis 
of personality disorder was entered as a covariate in the analysis.
 Results 
 Patients’ Progress through the Trial 
 All 83 patients and their partners were randomized, 
following assessment, to the 3 treatment conditions. Of 
the 35 patients, who were randomized to MFT, 6 (17.1%) 
dropped out from treatment: 1 patient did not start ther-
apy and another 5 patients stopped attending the group 
early. No follow-up data were available for 8 patients at 3 
months (22.9%; 4 dropouts and 4 completers) and 10 pa-
tients at 15 months (28.6%; 5 dropouts and 5 completers) 
since they did not return the questionnaires. Patients in 
this treatment condition participated on average in 5.4  8 
1.8 sessions and their 34 partners in 5.1  8 2 sessions. 
Thirty-six of their children (mean age: 15.5 years, range: 
5–32 years, 19 boys and 17 girls) participated on average 
in 1.3 sessions.
 In SFT, 3 patients (12%) dropped out from treatment: 
1 patient did not start therapy and another 2 patients 
stopped the family sessions early. The patients partici-
pated on average in 6.8  8 0.6 sessions and their partners 
in 6.7  8 0.8 sessions. Thirty-four of their children (mean 
age: 14.1 years, range: 6–30 years, 16 girls and 18 boys) 
participated on average in 1.3 sessions. Six patients at 3 
months (24%; 3 dropouts and 3 completers) and 8 pa-
tients at 15 months (32%; 3 dropouts and 5 completers) 
did not return the questionnaires.
 In the TAU condition, questionnaires were not filled 
out by 10 patients at 3 months (43.5%) and 12 patients at 
15 months (52.2%). Despite the higher frequency of lost 
data in the TAU condition, no statistically significant dif-
ferences in the frequency of lost data were found between 
the 3 treatment conditions at 3 months (  2 = 3.3, d.f. = 2, 
p = 0.19) and 15 months (  2 = 3.6, d.f. = 2, p = 0.16). The 
group of patients who did not complete their assessments 
at 3 and 15 months did not differ from those who did, 
with one exception in that they had a more frequent co-
morbid diagnosis of substance abuse at baseline (29.1 vs. 
6.8%,   2 = 9.4, d.f. = 3, p  ! 0.05, and 26.71 vs. 5.7%,   2 = 
9.0, d.f. = 3, p  ! 0.05, respectively).
 No differences were found in treatment dropout rates 
between the 2 family therapy conditions (  2 = 0.3, d.f. = 
1, p = 0.58). Dropouts from SFT and MFT were signifi-
cantly older (51.0 vs. 41.6 years, F = 10.6, d.f. = 81, p  ! 
0.005), with a longer relationship (23.9 vs. 16.6 years, F = 
4.4, d.f. = 82, p  ! 0.05), were hospitalized for a shorter 
period (9.4 vs. 12.3 weeks, F = 4.6, d.f. = 82, p  ! 0.05), were 
more likely to be males (55.6 vs. 24.3%,   2 = 3.9, d.f. = 1, 
p  ! 0.05) and had more frequent diagnoses of comorbid-
ity, especially substance abuse (44.4 vs. 9.5%,   2 = 9.5,
d.f. = 3, p  ! 0.05) at baseline.
 Effects of Treatment 
 Overall, the BDI scores decreased significantly over 
time in all treatment conditions (F = 39.52, d.f. = 1, p  ! 
0.0001;  table 2 ), but the observed differences between 
treatments, which seemed to favour MFT and SFT in 
comparison with TAU, were not statistically significant 
(F = 1.29, d.f. = 2, p = 0.28). Between the 3-month and 15-
month follow-up there were continuing improvements in 
mood in patients in the two family treatments, but BDI 
scores remained unchanged for those in TAU.
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 Table 2 shows that at 15 months the proportion of 
treatment responders (i.e. with an improvement in BDI 
scores of at least 50%)  was significantly higher in the fam-
ily treatments than in TAU (  2 = 11.12, d.f. = 2, p  ! 0.005). 
A paired comparison showed a significant difference be-
tween MFT and TAU (p = 0.001, Fisher’s test) and be-
tween MFT and SFT (p = 0.047, Fisher’s test), but not be-
tween SFT and TAU. There was a similar pattern favour-
ing MFT and SFT for patients in remission (a BDI score 
 ! 9), but this difference did not reach statistical signifi-
cance. There were also no significant differences in re-
hospitalization, suicide rates and in use of psychiatric 
outpatient services in the period between discharge and 
15 months.
 All but one patient in the study were taking antide-
pressants at baseline, and this was still true of approxi-
mately 85% at follow-up. However, this varied signifi-
cantly between treatments. At the 15-month follow-up, 
none of those in TAU had stopped using antidepressants, 
whereas 16% of those in SFT and 26% in MFT had stopped 
(  2 = 6.95, d.f. = 2, p  ! 0.05). In the 2-way comparisons at 
15 months, the MFT versus TAU comparison was statis-
tically significant (p = 0.007, Fisher’s test), while the TAU 
versus SFT was just outside the 5% level of significance
(p = 0.06, Fisher’s test). People may of course discontinue 
the use of antidepressants for a variety of reasons other 
than improvements in mood. We therefore compared the 
BDI scores of those who were not taking medication with 
those who were. The mean scores (6.0  8 8.7 and 18.8  8 
12.6, respectively) were significantly different (t = 3.35, 
d.f. = 48, p  ! 0.005). In fact, only 2 of the 13 patients who 
were not using antidepressants had BDI scores  1 9.
 SEH as Perceived by the Partner 
 An important aspect of family interventions is explor-
ing the different perceptions that family members have of 
each other as these influence behaviours, beliefs and self-
perceptions. The significance of this is revealed in the 
changes of partners’ perceptions of each others’ emotion-
al health ( table 2 ). The SEH as perceived by the partner 
Table 2. Effects of treatment on depressive symptoms, re-hospitalization rates, SEH and medication use
MFT (n = 35) TAU (n = 23) SFT (n = 25) p value
BDI
Baseline
3 months
15 months
26.689.9
18.789.1
15.8813.7
27.3810.7
21.9810.8
22.2815.6
26.2813.5
19.3810.7
12.589.8
ns
ns
ns
Treatment responders
3 months
15 months
8 (22.9)
17 (48.6) 
3 (13.0)
2 (8.7)
5 (20.0)
6 (24.0)
ns
0.004a
Treatment remission
3 months
15 months
7 (20.0)
13 (37.1)
3 (13.0)
4 (17.4)
4 (16.0)
7 (28.0)
ns
ns
Re-hospitalization rates at 15 months 8 (23.5) 7 (33.3) 3 (12.5) ns
Suicide rates at 15 months 0 (0) 1 (4.3) 1 (4.0) ns
Not using antidepressant medication
Baseline
3 months
15 months
1 (2.9)
3 (8.6)
9 (25.7)
0 (0)
2 (8.7)
0 (0)
0 (0)
1 (4.0)
4 (16.0)
ns
ns
0.031b
SEH of partner by the patient
Baseline
3 months
15 months
2.880.5
3.280.5
3.380.5
2.980.6
3.080.8
3.080.9
2.980.7
3.380.6
3.280.6
ns
ns
ns
SEH of patient by the partner
Baseline
3 months
15 months
1.780.8
2.680.6
2.780.6
1.680.7
1.980.8
3.180.3
1.780.9
2.380.8
3.080.4
ns
0.029c
ns
Psychiatric consultations after discharge 16.5821.2 11.6810.3 11.188.6 ns
Values are given as means 8 SD. Figures in parentheses are percentages.
a 2 = 11.12, d.f. = 2, p < 0.005. b 2 = 6.95, d.f. = 2, p < 0.05. c F = 3.8, d.f. = 2, p < 0.05.
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differed significantly over time, the treatment condition 
and the patients/partners with a statistically significant 
time  ! treatment (F = 3.0, d.f. = 4, p  ! 0.05) and partner/
patient  ! time  ! treatment effect (F = 4.8, d.f. = 4, p  ! 
0.005). The patients did not report an improvement in the 
SEH of their partners in TAU, in contrast with the pa-
tients in the 2 family treatments. Moreover, the patients 
in MFT and SFT were seen as improved by their partners 
on the SEH at both 3 and 15 months, whereas the patients 
in TAU were only reported to be improved by their part-
ners at 15 months. At 3 months, the SEH of the patient as 
perceived by the partner differed significantly between 
treatments (F = 3.8, d.f. = 2, p  ! 0.05), but by the time of 
the follow-up the difference had disappeared. More de-
tailed contrast analysis using a 2-way comparison (MFT 
vs. TAU, MFT vs. SFT, SFT vs. TAU) for the patients and 
the partners separately revealed a significant time  ! 
treatment interaction for the patients (F = 3.9, d.f. = 2,
p  ! 0.05) as well as for the partners (F = 6.48, d.f. = 2,
p  ! 0.01) only when comparing MFT with TAU. 
 Observed Cases Analysis 
 In order to check for potential bias arising out of using 
the last available measurements to replace missing data 
these analyses were repeated using a reduced data set 
omitting participants with missing data  [40] . The results 
remained essentially the same with all statistically sig-
nificant findings remaining significant. The one excep-
tion was the difference in the proportion of treatment 
responders found between MFT and SFT, which in the 
more restricted dataset was not statistically significant
(p = 0.08, Fisher’s test).
 Discussion 
 This study investigated the effects of adding single- or 
multi-family therapy to the treatment of hospitalized pa-
tients with major depression. Before discussing our find-
ings, potential limitations need to be addressed. The first 
is that almost twice as many participants in TAU did not 
return questionnaires compared with the other treat-
ments. Withdrawal from research (typically 25% and up 
to 50%) is a frequent problem in treatment trials for de-
pression  [41, 42] , but it is of particular concern if it is not 
balanced between treatments. If we assume that those 
who failed to return questionnaires include a larger pro-
portion of patients not doing well, the results would be 
skewed either in favour of family therapy (if missing data 
are being replaced) or in favour of TAU (if cases with 
missing data are omitted from the analysis). The fact that 
the 2 ways of dealing with missing data that we used led 
to essentially the same findings goes some way towards 
mitigating these concerns. The less subjective finding 
that there were differences between the treatments in the 
use of antidepressants at follow-up also increases the con-
fidence in the results.
 The relatively small size of the sample was a further 
limitation, increasing the risk of false-negative conclu-
sions and requiring a degree of caution when interpreting 
the results,  particularly the relative lack of differentiation 
between MFT and SFT. The study would also have been 
strengthened if available resources had allowed the use of 
observer ratings at follow-up. However, the BDI is a ro-
bust self-report measure for the assessment of depression 
severity and change  [43, 44] .
 Bearing the above caveats in mind, the results of this 
study provide additional evidence for the role of family 
therapy in the treatment of depression. While there were 
significant improvements in all patients over time, the 
decrease of depressive symptoms was more pronounced 
for patients receiving a family intervention compared to 
those in TAU. It was notable that the depression in TAU 
patients decreased mainly in the first 3 months, whereas 
the patients in both family treatments continued to im-
prove throughout follow-up – a finding similar to that 
reported by Leff et al.  [19] . At 15 months, less than 10% 
of those in TAU were classified as ‘treatment responders’, 
whereas a quarter of those in SFT and nearly half of those 
in MFT reached this criterion; a finding similar to that of 
Miller et al.  [23] , showing the value of adjunctive family 
therapy following hospital treatment. It is important to 
note that in spite of the extensive treatment, the response 
and remissions rates were quite modest at follow-up. This 
may partly reflect the difficulties in achieving recovery 
for this particular group of recurrently depressed patients 
with high psychiatric comorbidity, and the importance of 
developing alternate or sequential forms of treatments  [6, 
45, 46] . The limited treatment response, however, could 
also be due to the relatively brief family intervention (7 
sessions), and it is possible that a longer treatment might 
have led to greater improvements.
 The patients in the 2 family intervention groups, but 
particularly those in the multi-family group, were using 
less antidepressant medication at 15 months than pa-
tients receiving TAU. Our data suggest that this was at 
least in part due to the patients being less depressed, but 
caution is needed in interpreting this finding given the 
evidence that lower doses of antidepressants can be as-
sociated with higher relapse rates  [47] .
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 The family treatments had an additional advantage 
compared to TAU in that they helped partners to recog-
nize the improvements in mood sooner (at 3 months for 
partners in SFT or MFT compared to 15 months in TAU). 
This could have been due to an increase in their aware-
ness of the patient’s condition allowing them to notice 
more readily improvements in mood, or alternately the 
focus of the family discussions on positive aspects of the 
patient’s functioning could have helped the partners put 
the depression more quickly into perspective.
 Differences between the 2 family interventions were 
relatively small. MFT was more clearly differentiated on 
a number of measures (use of medication, responder 
rates, subjective emotional health of patients and their 
partners) from TAU than was the case for SFT. Although 
we found a significant difference in the proportion of re-
sponders between the 2 family interventions, this finding 
needs to be interpreted with caution given the limitations 
described earlier. Nevertheless, the finding is consistent 
with other research which has shown MFT to be at least 
as effective or more so in reducing symptoms and/or re-
lapse rates than single-family interventions in the treat-
ment of schizophrenia  [48–52] or eating disorder  [53] , for 
example. Additional benefits of MFT found in other 
studies (e.g. improved communication, overcoming stig-
matization and reduction of social isolation  [34, 54–58] ) 
were not addressed in this study and need more investi-
gation in depression. Future research should also pay at-
tention to the question of economic health costs of both 
types of family interventions.
 Our study indicates that both SFT and particularly 
MFT may benefit hospitalized patients with major de-
pression, improving treatment response and reducing the 
use of medication, although these results should be rep-
licated before being implemented in routine clinical set-
tings. The differences between treatments in the way 
partners’ perceptions of the patients’ well-being evolved 
points to a potentially important area for future investi-
gation as this might be a possible mediator of treatment. 
We found insufficient evidence to be able to say with con-
fidence that MFT confers greater benefit in the treatment 
of depression than SFT. Nevertheless, the clearer findings 
of changes in both patients and their partners in response 
to MFT point to the potential value of this treatment, and 
the need for further research to evaluate the effectiveness 
of MFT for depression and the therapeutic mechanisms 
that underpin it.
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